Drug Shortage Report for CEFOXITIN FOR INJECTION

Last updated on 2020-05-14 History
Report ID 86614
Drug Identification Number 02240773
Brand name CEFOXITIN FOR INJECTION
Common or Proper name CEFOXITIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFOXITIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-13
Estimated end date
Actual end date 2020-05-08
Shortage status Resolved
Updated date 2020-05-14
Company comments This item is discontinued
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-05-14 French Compare
v10 2020-05-14 English Compare
v9 2019-08-29 French Compare
v8 2019-08-29 English Compare
v7 2019-08-06 French Compare
v6 2019-08-06 English Compare
v5 2019-06-27 French Compare
v4 2019-06-27 English Compare
v3 2019-06-14 English Compare
v2 2019-06-13 French Compare
v1 2019-06-13 English Compare